Search this site:






Yale University
Dept. of Psychiatry
300 George Street
New Haven, CT
06511 USA

Tel: 203-785-2117

YUSM Logo
YSMInfo Library Calendar Directories Search Home

Department of Psychiatry Faculty


    Marek C. Chawarski, Ph.D.
Assistant Professor of Psychiatry

Substance Abuse Center
24 Park St - CMHC
New Haven, CT 06508

Tel: 203-974-7602
Fax: 203-974-7606
Email: marek.chawarski@yale.edu

Education
M.A., 1987, Jagiellonian University, Krakow, Poland
M.S., 1992, Yale University, 1992
M.Phil., 1993, Yale University, 1993
Ph.D., 1995, Yale University

Academic and Research Interest
My primary research interest is in developing novel treatment interventions for patients with substance abuse disorders, in particular opiate-dependent individuals. My current research activities are focused on developing behaviorally oriented psychosocial interventions targeting depressive symptoms and drug use for patients with persistent depressive symptoms in order to improve their response to treatment and increase their chances of succeeding in treatment. I am also involved in multiple international research efforts to improve substance abuse treatments, with emphasis on culturally appropriate evidence-based treatments. My teaching and educational efforts are focused on training therapists, drug counselors, and other medical and non-medical personnel in providing behaviorally oriented psychosocial interventions for patients receiving agonist maintenance treatments, or other forms of pharmacological and drug-free treatments for opiate dependence.

Areas of Expertise:
Development and evaluation of substance abuse treatments
Psychosocial treatments for substance abuse disorders
Clinical research methodology and statistics

Publications of Note

Fiellin, D.A., O'Connor, P.G., Chawarski, M., Schottenfeld, R.S. (2004). Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care. American Journal on Addictions, 13, 67-78.

Baird, J.C. & Chawarski, M.C., (2005). Context-Constrained Judgment of the Perceived Risk of HIV/AIDS. Journal of Applied Social Psychology, 35, 1, 29-60.

Schottenfeld, R.S., Chawarski, M.C., Pakes, J. R.; Pantalon, M.V., Carroll, K.M., & Kosten, T.R. (2005). Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence. American Journal of Psychiatry, 162, 340-349.

Sullivan, L.E., Chawarski, M.C., O'Connor, P.G., Schottenfeld, R.S., & Fiellin, D.A. (2005). The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug and Alcohol Dependence, 79, 113-116.

Chawarski, M.C., Moody, D.E., Pakes, J., O'Connor, P.G., & Schottenfeld, R.S. (2005). Bupprenorphine tablet versus liquid: A clinical trial comparing plasma levels, efficacy and symptoms. Journal of Substance Abuse Treatment, 29, 307-312.

Chawarski, M.C., Mazlan, M., & Schottenfeld, R.S. (in press). Heroin dependence and HIV infection in Malaysia. Drug and Alcohol Dependence.

Last modified:  March 21, 2006


Up YNHH YNHMC YaleInfo